Immuron Ltd ADR

Immuron Ltd ADR EBIT per Share

The EBIT per Share of Immuron Ltd ADR (IMRN) as of Nov 3, 2026 is -0.57 USD. In the previous year, EBIT per Share was -0.54 USD — a change of 4.92% (lower).

EBIT per Share

-0.57USD

YoY

4.92%

Last updated:

EBIT per Share of Immuron Ltd ADR is 2026 -0.57 USD. EBIT per Share of Immuron Ltd ADR was 2025 -0.54 USD. It decreases by 4.92% lower compared to the previous year.

The Immuron Ltd ADR EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-1.03 USD
Jan 1, 2022
-0.35 USD
Jan 1, 2023
-0.44 USD
Jan 1, 2024
-0.71 USD
Jan 1, 2025
-0.54 USD
Jan 1, 2026
-0.57 USD
Jan 1, 2027 (e)
-0.01 USD
Jan 1, 2028 (e)
0.00 USD
The Immuron Ltd ADR EBIT per Share history
YEAREBIT per ShareYoY
est0.00USD-100.00%
est-0.01USD-98.35%
-0.57USD+4.92%
-0.54USD-23.17%
-0.71USD+62.03%
-0.44USD+24.36%
-0.35USD-65.82%
-1.03USD+176.45%
-0.37USD+1,929.61%
-0.02USD-97.24%
-0.66USD-63.08%
-1.79USD-19.35%
-2.23USD+41.03%
-1.58USD-0.75%
-1.59USD-54.24%
-3.47USD-60.87%
-8.88USD+37.16%
-6.47USD+16.87%
-5.54USD-36.47%
-8.72USD-61.38%
-22.58USD-33.06%
-33.73USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Immuron Ltd ADR Stock analysis

What does Immuron Ltd ADR do? Immuron Ltd ADR is a biopharmaceutical company listed on the US market in 2017, operating from Carlton. The firm engages in the research, development, and commercialization of polyclonal antibodies across Australia, the United States, and Canada. It operates through Research and Development and Hyper-immune Products segments. Immuron offers Travelan, an over-the-counter medicine and dietary supplement for digestive health, and Protectyn, an immune supplement. The company also develops clinical-stage candidates, including Travelan (IMM-124E) and IMM-529 for gastrointestinal conditions, alongside the pre-clinical IMM-986. Additionally, Immuron provides a technology platform and maintains collaborations for therapeutic development. Immuron Ltd ADR is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Immuron Ltd ADR stock

EBIT per Share of Immuron Ltd ADR is -0.57 USD in 2026.

EBIT per Share of Immuron Ltd ADR changed from -0.54 USD to -0.57 USD, representing a 4.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Immuron Ltd ADR since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Immuron Ltd ADR

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Immuron Ltd ADR